Topic
Pathology
From whole-slide imaging to AI-assisted diagnosis, our pathology events explore how digital and computational tools are transforming histopathology, primary diagnosis and translational research.
- Digital pathology and whole-slide imaging
- AI and machine learning for primary diagnosis
- Computational pathology in clinical research
About Pathology at Global Engage
Pathology is undergoing its most significant transformation in decades. Whole-slide imaging is now routine in many labs; AI-assisted primary diagnosis is moving from research use to regulated deployment; and computational pathology is unlocking translational biomarkers that were invisible on glass.
Global Engage's pathology programme convenes chief pathologists, digital transformation leads, AI vendors and the pharma teams using pathology data to guide translational decisions. The agenda focuses on the operational reality of digital deployment — workflow, validation, storage, and getting reporting pathologists on side.
Tracks cover WSI infrastructure and IT integration, AI validation and regulatory frameworks, computational biomarkers for clinical trials, telepathology and cross-site reporting, and the workforce transformation required to make digital pathology routine.
Upcoming Pathology conferences
Digital Pathology and AI Congress
The advances and applications of digital pathology; artificial intelligence and machine learning for primary diagnosis and clinical research.
- Dates
- 9–10 Dec 2026
- Location
- London, UK
Reports
View allSelf-learning AI: a boost for digital pathology
Self-learning artificial intelligence approaches are offering a number of advantages for digital pathology when compared to established AI options
Videos
View allSlide decks
View allSpatial Omics in Lung Cancer: Merging Transcriptomics and Proteomics for Deeper Insights
Slides: Kimberly Smythe, Head of Translational Pathology, Fred Hutchinson Cancer Center
Clinical Biomarkers and Therapy Candidates via Spatial Analysis
Slides: Alexander Xu, Assistant Professor of Bioengineering, University of Maryland
Reimagining Pathology: A Seamless Transformation from Slides to Generative Insight
Slides: Osamu Iizuka, CEO, Medmain Inc.
Making the Business Case for Digital Pathology in Pharma and Consultancy
An Interview with Dr. Elizabeth Neyens
Related topics
FAQs
Pathology at Global Engage — questions we hear most
Get the briefing
Stay ahead in Pathology
Monthly updates on upcoming conferences, new research and industry moves in this space.